Sitafloxacin (Gracevit) 50 mg: A Precision-Dosed Fluoroquinolone in Tablet Form

Combating bacterial infections demands not only a potent antimicrobial but also a convenient, precisely dosed formulation. Sitafloxacin 50 mg, marketed under the brand name Gracevit, is the tablet-based presentation of Japan's latest-generation fluoroquinolone. The 100-tablet pack supports an extended therapeutic course, while the 50 mg dosage strength itself renders the drug a flexible tool for constructing individualized treatment regimens — a physician may prescribe either one or two tablets daily, depending on infection severity and patient-specific factors.

🔬 Why Sitafloxacin: Pharmacological Superiority

Sitafloxacin occupies a distinctive place within the fluoroquinolone family, owing to several structural and functional differentiators from its predecessors:

• Overcoming Resistance. The drug retains bactericidal activity against strains that have developed resistance to levofloxacin, ciprofloxacin, and other fluoroquinolones. This is achieved through the balanced inhibition of two vital bacterial enzymes — DNA-gyrase and topoisomerase IV. The emergence of resistance requires simultaneous mutations in the genes encoding both targets, a statistically rare event.
• Expanded Spectrum. Beyond the standard fluoroquinolone coverage of Gram-negative and Gram-positive aerobes, sitafloxacin demonstrates clinically meaningful activity against anaerobic bacteria. This renders it a valuable option in mixed aerobic-anaerobic infections.
• High Bioavailability. Following oral ingestion, the drug is rapidly and completely absorbed, reaching therapeutic concentrations in pulmonary tissue, bronchial mucosa, renal parenchyma, the urinary tract, and ENT organs.

📋 Therapeutic Niches: What Gracevit 50 mg Treats

Sitafloxacin's efficacy has been validated in randomized, double-blind, multicenter active-controlled trials. The drug holds formal approval in Japan for the following indications:

1. Respiratory Tract Infections:

• Community-acquired pneumonia — sitafloxacin demonstrated efficacy non-inferior to both levofloxacin and tosufloxacin.
• Acute exacerbation of chronic bronchopulmonary diseases of bacterial origin.

2. Urinary Tract Infections:

• Complicated UTIs — the drug was compared to levofloxacin and proved comparable in therapeutic outcomes.

3. Rare but Significant Indications:

• Buruli ulcer (a cutaneous infection caused by Mycobacterium ulcerans).

4. ENT and Dental Infections:

• Bacterial sinusitis, tonsillitis, pharyngitis.
• Odontogenic infections of the maxillofacial region.

5. Urogenital Infections:

• Male urethritis.
• Chlamydial cervicitis in women.

💊 Tablet Form: Convenience and Precision

• Dosage Strength: 50 mg of sitafloxacin per tablet.
• Pack Size: 100 tablets — designed to cover a course spanning 1 to 3 months, depending on the daily dose.
• Standard Daily Dose: 50 mg (1 tablet) once daily. In severe or complicated infections, the physician may escalate the dose to 100 mg (2 tablets) per day.
• Administration: The tablet is swallowed whole with a glass of water. Food intake does not significantly impair absorption.
• Adherence: To sustain stable blood concentrations of the antibiotic, it is advisable to take the medication at the same time each day.

⚠️ Safety Profile

Clinical data indicate that the most commonly reported adverse reactions with oral sitafloxacin are:

• Gastrointestinal: Nausea, abdominal discomfort, diarrheal syndrome.
• Laboratory Shifts: Transient deviations in biochemical markers of hepatic and renal function, plus changes in hematological parameters.

Class-specific precautions applicable to all fluoroquinolones include:

• The risk of tendinitis and tendon rupture (especially in patients over 60 years of age and those receiving systemic glucocorticosteroids).
• Potential QT interval prolongation — exercise caution in individuals with underlying cardiovascular pathology.
• Photosensitivity — intense solar and ultraviolet exposure should be avoided throughout the treatment period.

📦 Storage Instructions

Tablets must be kept in the original manufacturer's packaging, in a dry, light-protected location at room temperature. Keep out of the reach of children.

📦Find out about the delivery to your country on WhatsApp